Europe Clinical Trial Patient Recruitment Services Market Size & Outlook
Europe clinical trial patient recruitment services market, 2018-2030 (US$M)
Related Markets
Europe clinical trial patient recruitment services market highlights
- The Europe clinical trial patient recruitment services market generated a revenue of USD 240.5 million in 2023.
- The market is expected to grow at a CAGR of 8.5% from 2024 to 2030.
- In terms of segment, phase iii was the largest revenue generating phase in 2023.
- Phase I is the most lucrative phase segment registering the fastest growth during the forecast period.
- Country-wise, Italy is expected to register the highest CAGR from 2024 to 2030.
Europe data book summary
| Market revenue in 2023 | USD 240.5 million |
| Market revenue in 2030 | USD 424.9 million |
| Growth rate | 8.5% (CAGR from 2023 to 2030) |
| Largest segment | Phase iii |
| Fastest growing segment | Phase I |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Phase I, Phase II, Phase III, Phase IV |
| Key market players worldwide | Thermo Fisher Scientific Inc, IQVIA Holdings Inc, Clara Health, Antidote Health, BBK Worldwide, Clariness, Costas Inc, Worldwide Clinical Trials, Veristat, Elligo Health Research |
Other key industry trends
- In terms of revenue, Europe region accounted for 26.5% of the global clinical trial patient recruitment services market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 337.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Clinical Trial Patient Recruitment Services Market Scope
Clinical Trial Patient Recruitment Services Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Europe clinical trial patient recruitment services market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical trial patient recruitment services market will help companies and investors design strategic landscapes.
Phase iii was the largest segment with a revenue share of 57.38% in 2023. Horizon Databook has segmented the Europe clinical trial patient recruitment services market based on phase i, phase ii, phase iii, phase iv covering the revenue growth of each sub-segment from 2018 to 2030.
Europe holds the second-largest share in the global clinical trial patient recruitment services market owing to the presence of reputed biopharmaceutical companies, such as F. Hoffmann-La Roche Ltd. (Switzerland) and Novartis (Switzerland).
High R&D spending and an increase in the number of clinical trials in European countries are further contributing to market growth. A developed infrastructure for clinical trials and the presence of skilled personnel support market growth in the region.
In addition, CROs, such as PPD, Inc., and Icon Plc, have centers in European countries, including the UK, Germany, and France, which is expected to further contribute to market growth in this region.
Reasons to subscribe to Europe clinical trial patient recruitment services market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe clinical trial patient recruitment services market databook
-
Our clientele includes a mix of clinical trial patient recruitment services market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe clinical trial patient recruitment services market , including forecasts for subscribers. This continent databook contains high-level insights into Europe clinical trial patient recruitment services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Europe Clinical Trial Patient Recruitment Services Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
